GoodRx Holdings (GDRX) Non-Current Assets (2019 - 2026)

GoodRx Holdings' Non-Current Assets history runs 8 years deep, the most recent figure standing at $754.8 million for Q1 2026.

• In Q1 2026, Non-Current Assets changed 0.04% year-over-year to $754.8 million; the TTM figure through Mar 2026 stood at $3.0 billion (up 3.65% YoY), while the FY2025 annual figure was $761.0 million, up 4.41% from the prior year.
• Non-Current Assets came in at $754.8 million for Q1 2026 at GoodRx Holdings, down from $761.0 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $772.8 million in Q2 2023 to a low of $543.6 million in Q1 2022.
• A 5-year average of $720.5 million and a median of $728.0 million in 2024 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets surged 40.25% in 2022 and dropped 6.21% in 2024, its largest moves.
• GoodRx Holdings' Non-Current Assets stood at $684.9 million in 2022, then grew by 4.54% to $716.0 million in 2023, then climbed by 1.79% to $728.8 million in 2024, then increased by 4.41% to $761.0 million in 2025, then slipped by 0.81% to $754.8 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $754.8 million, $761.0 million, and $760.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison